Eqis Capital Management, Inc. Haemonetics Corp Transaction History

Eqis Capital Management, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$74.34 - $121.82 $160,128 - $262,400	-2,154 Closed	0 $0
Q4 2019 Jan 24, 2020	BUY	$114.37 - $129.46 $246,352 - $278,856	2,154 New	2,154 $248,000
Q4 2018 Jan 25, 2019	SELL	$90.66 - $116.63 $381,587 - $490,895	-4,209 Closed	0 $0
Q3 2018 Oct 17, 2018	SELL	$89.96 - $114.58 $56,764 - $72,299	-631 Reduced 13.04%	4,209 $474,000
Q2 2018 Jul 27, 2018	BUY	$71.53 - $95.75 $346,205 - $463,430	4,840 New	4,840 $434,000
Q1 2018 Apr 06, 2018	SELL	$60.72 - $74.41 $412,956 - $506,062	-6,801 Closed	0 $0
Q4 2017 Jan 25, 2018	SELL	$44.96 - $58.99 $78,814 - $103,409	-1,753 Reduced 20.49%	6,801 $395,000
Q3 2017 Oct 03, 2017	BUY	$40.38 - $44.87 $345,410 - $383,817	8,554	8,554 $384,000

332

53.8M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.02B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Eqis Capital Management, Inc. with notifications on news.